Current and historical daily PE Ratio for Nectar Lifesciences Ltd (
LUX:NECLF
) from 2010 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Nectar Lifesciences stock (LUX:NECLF) PE ratio as of Jun 10 2024 is 142.91.
More Details
Nectar Lifesciences Ltd (LUX:NECLF) PE Ratio (TTM) Chart
Nectar Lifesciences Ltd (LUX:NECLF) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1278
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Nectar Lifesciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 125.3 | 2024-04-05 | 144.0 |
| 2024-06-07 | 125.3 | 2024-04-04 | 140.0 |
| 2024-06-06 | 122.0 | 2024-04-03 | 141.3 |
| 2024-06-05 | 120.0 | 2024-04-02 | 120.7 |
| 2024-06-04 | 116.0 | 2024-03-28 | 120.7 |
| 2024-06-03 | 130.7 | 2024-03-27 | 72.4 |
| 2024-05-31 | 126.0 | 2024-03-26 | 73.6 |
| 2024-05-30 | 127.3 | 2024-03-25 | 75.6 |
| 2024-05-29 | 129.3 | 2024-03-22 | 75.6 |
| 2024-05-28 | 129.3 | 2024-03-21 | 74.8 |
| 2024-05-27 | 132.7 | 2024-03-20 | 74.0 |
| 2024-05-24 | 135.3 | 2024-03-19 | 76.0 |
| 2024-05-23 | 133.3 | 2024-03-18 | 75.2 |
| 2024-05-22 | 133.3 | 2024-03-15 | 76.0 |
| 2024-05-21 | 133.3 | 2024-03-14 | 76.4 |
| 2024-05-20 | 136.0 | 2024-03-13 | 72.8 |
| 2024-05-17 | 136.0 | 2024-03-12 | 80.0 |
| 2024-05-16 | 136.7 | 2024-03-11 | 82.0 |
| 2024-05-15 | 142.7 | 2024-03-08 | 86.0 |
| 2024-05-14 | 130.7 | 2024-03-07 | 86.0 |
| 2024-05-13 | 132.0 | 2024-03-06 | 84.8 |
| 2024-05-10 | 132.7 | 2024-03-05 | 84.8 |
| 2024-05-09 | 134.0 | 2024-03-04 | 88.0 |
| 2024-05-08 | 140.0 | 2024-03-01 | 90.0 |
| 2024-05-07 | 134.7 | 2024-02-29 | 92.4 |
| 2024-05-06 | 140.7 | 2024-02-28 | 90.0 |
| 2024-05-03 | 138.7 | 2024-02-27 | 93.2 |
| 2024-05-02 | 140.7 | 2024-02-26 | 96.0 |
| 2024-04-30 | 137.3 | 2024-02-23 | 97.6 |
| 2024-04-29 | 138.7 | 2024-02-22 | 100.0 |
| 2024-04-26 | 140.7 | 2024-02-21 | 99.2 |
| 2024-04-25 | 136.7 | 2024-02-20 | 107.0 |
| 2024-04-24 | 138.0 | 2024-02-19 | 107.0 |
| 2024-04-23 | 136.7 | 2024-02-16 | 104.0 |
| 2024-04-22 | 137.3 | 2024-02-15 | 89.2 |
| 2024-04-19 | 135.3 | 2024-02-14 | 88.4 |
| 2024-04-18 | 134.0 | 2024-02-13 | 83.6 |
| 2024-04-17 | 137.3 | 2024-02-12 | 83.6 |
| 2024-04-16 | 137.3 | 2024-02-09 | 87.6 |
| 2024-04-15 | 130.0 | 2024-02-08 | 91.2 |
| 2024-04-12 | 136.0 | 2024-02-07 | 89.6 |
| 2024-04-11 | 139.3 | 2024-02-06 | 90.8 |
| 2024-04-10 | 139.3 | 2024-02-05 | 87.6 |
| 2024-04-09 | 140.0 | 2024-02-02 | 90.0 |
| 2024-04-08 | 141.3 | 2024-02-01 | 88.0 |
Nectar Lifesciences Ltd (LUX:NECLF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Nectar Lifesciences Ltd
ISIN : US63975T1051
Share Class Description:
LUX:NECLF: ADRCompare
Compare
Traded in other countries / regions
NECLIFE.IndiaNECLF.Luxembourg IPO Date
2010-03-01Description
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers